angiogenesis in viral immunoinflammatory lesions
DESCRIPTION
Angiogenesis in Viral Immunoinflammatory Lesions. Barry T. Rouse University of Tennessee Part 4. Does control of angiogenesis represent a smart approach to control stromal keratitis?. Problem: many factors to deal with. EMAP II Endothelial Monocyte Activating Polypeptide. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Angiogenesis in Viral Immunoinflammatory Lesions](https://reader035.vdocuments.mx/reader035/viewer/2022062519/56815349550346895dc15e3e/html5/thumbnails/1.jpg)
Angiogenesis in Viral Immunoinflammatory
Lesions
Barry T. RouseUniversity of Tennessee
Part 4
![Page 2: Angiogenesis in Viral Immunoinflammatory Lesions](https://reader035.vdocuments.mx/reader035/viewer/2022062519/56815349550346895dc15e3e/html5/thumbnails/2.jpg)
Does control of angiogenesis represent a smart approach to
control stromal keratitis?
• Problem: many factors to deal with
![Page 3: Angiogenesis in Viral Immunoinflammatory Lesions](https://reader035.vdocuments.mx/reader035/viewer/2022062519/56815349550346895dc15e3e/html5/thumbnails/3.jpg)
EMAP IIEndothelial Monocyte Activating Polypeptide
• Cytokine with several effects on neovascularization – Apoptosis of vascular endothelial cells– Upregulates TNF receptors – so TNF
induces apoptosis– Activates tissue factors and blood clots
• Proinflammatory effects• Rationale - targets growing blood
vessels so should inhibit effects of several angiogenic factors
![Page 4: Angiogenesis in Viral Immunoinflammatory Lesions](https://reader035.vdocuments.mx/reader035/viewer/2022062519/56815349550346895dc15e3e/html5/thumbnails/4.jpg)
0
10
20
30
40
0 10 100 1000
*
*
# o
f A
po
pto
tic
Cel
ls/H
PF
a
EMAP II (ng/ml)
Endo
Epi
Lim
b
EMAP II induces apoptosis in vascular endothelial cells in vitro and in vivo
![Page 5: Angiogenesis in Viral Immunoinflammatory Lesions](https://reader035.vdocuments.mx/reader035/viewer/2022062519/56815349550346895dc15e3e/html5/thumbnails/5.jpg)
0
5
10
15
20
An
gio
gen
esis
Sco
re
0 5 10 15 20 25
Days p.i.
Control
EMAP II
*
** *
*
c
i
ci
cc
cc
i
Control EMAP II
EMAP II suppresses neovascularization in murine HSK
D2 p.I.
D8 p.I.
D15 p.I.
![Page 6: Angiogenesis in Viral Immunoinflammatory Lesions](https://reader035.vdocuments.mx/reader035/viewer/2022062519/56815349550346895dc15e3e/html5/thumbnails/6.jpg)
HS
K L
esi
on
Sc
ore
0
1
2
3
4
5
0 5 10 15 20 25Days p.i.
Control
EMAP II
**
*
*
D8
D15
E FE FD15 D15
D15
D8Control EMAP II
EMAP II Suppresses HSK lesion score
![Page 7: Angiogenesis in Viral Immunoinflammatory Lesions](https://reader035.vdocuments.mx/reader035/viewer/2022062519/56815349550346895dc15e3e/html5/thumbnails/7.jpg)
Future approaches – possible siRNA targetingtargeting
multiple angiogenesis factors
![Page 8: Angiogenesis in Viral Immunoinflammatory Lesions](https://reader035.vdocuments.mx/reader035/viewer/2022062519/56815349550346895dc15e3e/html5/thumbnails/8.jpg)
Preliminary studyPreliminary study
• Plasmid encoding siRNA expressed following Plasmid encoding siRNA expressed following intra-stromal or sub-conjunctival injectionintra-stromal or sub-conjunctival injection
• Mixture of siRNA inhibiting VEGF and VEGF Mixture of siRNA inhibiting VEGF and VEGF receptors gave significant inhibition of receptors gave significant inhibition of
angiogenesis induced by CpGangiogenesis induced by CpG
![Page 9: Angiogenesis in Viral Immunoinflammatory Lesions](https://reader035.vdocuments.mx/reader035/viewer/2022062519/56815349550346895dc15e3e/html5/thumbnails/9.jpg)
Inhibition of CpG induced angiogenesis by siRNA delivery
CpG + siLacZ Day 4 CpG + siVEGF, R1, R2 Day 4
![Page 10: Angiogenesis in Viral Immunoinflammatory Lesions](https://reader035.vdocuments.mx/reader035/viewer/2022062519/56815349550346895dc15e3e/html5/thumbnails/10.jpg)
General Conclusions
• Herpes induced stromal keratitis an immunoinflammatory lesion
• Neovascularization a major step in pathogenesis
• HSV induces angiogenesis indirectly• Control of angiogenesis inhibits SK• Need multiple approaches for
satisfactory therapy
![Page 11: Angiogenesis in Viral Immunoinflammatory Lesions](https://reader035.vdocuments.mx/reader035/viewer/2022062519/56815349550346895dc15e3e/html5/thumbnails/11.jpg)
Colleagues Involved
• Dennis Klinman
• Margaret Schwartz
• Napoleone Ferrara
• Mei Zheng
• Bum-Seok Kim
• Kaustuv Banerjee
• Partha Biswas
• Sujin Lee